AR and prostate carcinoma: In prostate cancer, CAFs have been reported to produce IFN-γ and macrophage colony-stimulating factors in response to the activation of AR pathways [119]; thus, CAFs may promote PD-L1 expression in cancer cells through IFN-γ production.